Published in J Infect Dis on October 01, 1985
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol (1987) 6.16
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun (1989) 5.75
Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64
Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev (1989) 4.24
Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2. J Bacteriol (1986) 4.13
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87
Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun (1998) 2.27
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis. Infect Immun (1993) 2.15
Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J Clin Microbiol (1991) 2.11
Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene. J Clin Microbiol (1991) 2.09
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J Clin Microbiol (1998) 1.98
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J Clin Invest (1997) 1.93
Structures of and allelic diversity and relationships among the major outer membrane protein (ompA) genes of the four chlamydial species. J Bacteriol (1993) 1.90
Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol (2001) 1.90
Direct sequence evaluation of the major outer membrane protein gene variant regions of Chlamydia trachomatis subtypes D', I', and L2'. Infect Immun (1991) 1.89
Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies. Infect Immun (1985) 1.84
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78
Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism. J Bacteriol (2001) 1.70
Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J Bacteriol (2006) 1.70
Multi locus sequence typing of Chlamydiales: clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol (2008) 1.65
Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1). Sex Transm Infect (2001) 1.62
Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene. Infect Immun (1992) 1.60
Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin Med (1996) 1.54
Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars. J Clin Microbiol (1994) 1.48
Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer. J Bacteriol (2004) 1.44
Serotyping of Chlamydia psittaci isolates using serovar-specific monoclonal antibodies with the microimmunofluorescence test. J Clin Microbiol (1991) 1.44
General colorimetric method for DNA diagnostics allowing direct solid-phase genomic sequencing of the positive samples. Proc Natl Acad Sci U S A (1990) 1.43
Ultrastructural study of Chlamydia trachomatis surface antigens by immunogold staining with monoclonal antibodies. Infect Immun (1987) 1.33
Restriction endonuclease analysis of DNA from Chlamydia trachomatis biovars. J Clin Microbiol (1988) 1.32
Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections. J Clin Microbiol (1993) 1.30
Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci. J Clin Microbiol (1988) 1.29
Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol (2000) 1.27
Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis. Infect Immun (1994) 1.27
Polymorphic membrane protein H has evolved in parallel with the three disease-causing groups of Chlamydia trachomatis. Infect Immun (2003) 1.25
Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J Clin Microbiol (2010) 1.24
The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome. Infect Immun (2006) 1.22
Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun (1994) 1.22
Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun (1995) 1.20
Antigenic analysis of the major outer membrane protein of Chlamydia trachomatis with murine monoclonal antibodies. Infect Immun (1986) 1.20
Distribution study of Chlamydia trachomatis serovars among high-risk women in China performed using PCR-restriction fragment length polymorphism genotyping. J Clin Microbiol (2007) 1.19
Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. J Clin Microbiol (2004) 1.18
The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope. Infect Immun (1996) 1.18
Variability of the Chlamydia trachomatis omp1 gene detected in samples from men tested in male-only saunas in Melbourne, Australia. J Clin Microbiol (2004) 1.17
Production and partial characterization of monoclonal antibodies to four Chlamydia psittaci isolates. Infect Immun (1988) 1.14
Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1994) 1.14
Cloning and sequence analysis of the major outer membrane protein gene of Chlamydia psittaci 6BC. Infect Immun (1991) 1.07
Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol. J Clin Microbiol (1991) 1.07
Serovar distribution of urogenital C trachomatis isolates in Germany. Genitourin Med (1991) 1.05
Use of a reverse dot blot procedure to identify the presence of multiple serovars in Chlamydia trachomatis urogenital infection. J Clin Microbiol (2001) 1.03
Identification of individual genotypes of Chlamydia trachomatis from experimentally mixed serovars and mixed infections among trachoma patients. J Clin Microbiol (1994) 1.03
Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype. Infect Immun (2010) 1.00
Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates. J Clin Microbiol (1998) 1.00
Development of secondary inclusions in cells infected by Chlamydia trachomatis. Infect Immun (2005) 0.97
Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies. J Clin Microbiol (1991) 0.97
Identification of genus-specific epitopes on the outer membrane complexes of Chlamydia trachomatis and Chlamydia psittaci immunotypes 1 and 2. Infect Immun (1989) 0.96
Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens. J Clin Microbiol (2007) 0.95
Genetic variability among Chlamydia trachomatis reference and clinical strains analyzed by pulsed-field gel electrophoresis. J Clin Microbiol (1994) 0.91
Chlamydia trachomatis infections in infants. CMAJ (1989) 0.90
Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera. Infect Immun (1990) 0.90
Genotyping of Portuguese Chlamydia trachomatis urogenital isolates. Genitourin Med (1997) 0.89
Antibody response to epitopes of chlamydial major outer membrane proteins on infectious elementary bodies and of the reduced polyacrylamide gel electrophoresis-separated form. Infect Immun (1990) 0.89
Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay. J Clin Microbiol (1992) 0.88
In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun (1997) 0.83
Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages. Nat Commun (2016) 0.83
Genotyping of Chlamydia trachomatis by microsphere suspension array. J Clin Microbiol (2008) 0.81
Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars. Infect Immun (1996) 0.78
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology (2015) 0.76
Current problems of perinatal Chlamydia trachomatis infections. J Immune Based Ther Vaccines (2004) 0.75
Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples. J Mol Diagn (2011) 0.75
Rapid determination of lymphogranuloma venereum serovars of Chlamydia trachomatis by quantitative high-resolution melt analysis (HRMA). J Clin Microbiol (2012) 0.75
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol (1987) 6.16
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet (1999) 5.81
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest (1997) 4.51
Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2. J Bacteriol (1986) 4.13
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J (1978) 3.33
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell (1992) 3.07
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Construction of physical and genetic maps of Chlamydia trachomatis serovar L2 by pulsed-field gel electrophoresis. J Bacteriol (1992) 2.98
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Verbal report methods in clinical research on alcoholism: response bias and its minimization. J Stud Alcohol (1987) 2.70
Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun (1993) 2.68
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27